CATALOGO DEI PRODOTTI DELLA RICERCA

LANZAFAME, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.735
EU - Europa 1.384
AS - Asia 473
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 3
Totale 3.608
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.723
GB - Regno Unito 475
CN - Cina 419
SE - Svezia 186
IE - Irlanda 154
FR - Francia 139
IT - Italia 137
FI - Finlandia 107
DE - Germania 99
UA - Ucraina 34
KR - Corea 14
RU - Federazione Russa 14
VN - Vietnam 14
BE - Belgio 11
CA - Canada 9
TR - Turchia 9
NL - Olanda 5
BF - Burkina Faso 4
IN - India 4
CH - Svizzera 3
HU - Ungheria 3
RO - Romania 3
AU - Australia 2
BD - Bangladesh 2
ES - Italia 2
EU - Europa 2
GT - Guatemala 2
IL - Israele 2
JP - Giappone 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SA - Arabia Saudita 1
TW - Taiwan 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 3.608
Salva come PNG Salva come JPEG
Città #
Southend 416
Chandler 389
Jacksonville 244
Woodbridge 234
Dublin 154
Ann Arbor 140
Ashburn 90
Beijing 81
Lawrence 53
Princeton 53
Jinan 45
Helsinki 44
Nanjing 44
Wilmington 43
Shenyang 42
Houston 40
New York 30
Verona 30
Hebei 21
Ningbo 15
Tianjin 15
Haikou 14
Seoul 14
Bloomsbury 13
Sindelfingen 13
Zhengzhou 13
Brussels 11
Changsha 11
Hangzhou 11
Nanchang 11
Taizhou 11
Boardman 10
Jiaxing 10
Milan 10
Redmond 10
Guangzhou 9
Norwalk 9
Redwood City 9
Bologna 8
Dong Ket 8
Fuzhou 8
Clearwater 7
Lanzhou 7
Seattle 7
Toronto 7
Falls Church 6
San Francisco 6
Taiyuan 6
Washington 6
Pignone 5
Fairfield 4
Los Angeles 4
Ouagadougou 4
Riva 4
Scandiano 4
Vicenza 4
Brugherio 3
Budapest 3
Bursa 3
Düsseldorf 3
Giussano 3
Chicago 2
Edinburgh 2
Groningen 2
Guatemala City 2
Lancaster 2
London 2
Montréal 2
Novokuznetsk 2
Saint Louis 2
San Diego 2
Volargne 2
Albinea 1
Andover 1
Auburn Hills 1
Bangalore 1
Boston 1
Bratislava 1
Buenos Aires 1
Büdelsdorf 1
Cagliari 1
Cairo 1
Canberra 1
Castiglione Delle Stiviere 1
Changle 1
Chions 1
Copenhagen 1
Cormeilles-en-Parisis 1
Dallas 1
Dearborn 1
Dhaka 1
Dongguan 1
Esslingen am Neckar 1
Fushan 1
Indianapolis 1
Jakarta 1
Kampala 1
Kharkov 1
Kuala Lumpur 1
Kuwait City 1
Totale 2.582
Salva come PNG Salva come JPEG
Nome #
Performance of alere determine HIV-1/2 Ag/Ab combo rapid test for acute HIV infection: A case report | Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo nell?infezione acuta da HIV: Un caso clinic 115
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infection. 113
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 104
Primary cutaneous cryptococcosis in a HIV infested patient: case report. 95
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 91
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 89
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 89
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 89
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. 84
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 83
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 83
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 81
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 81
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 79
No improvement of lipodystrophy syndrome in an HIV-infected patient. 77
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 77
Antiretroviral therapy in low-resource settings 77
Raltegravir: is a 400 mg once-daily dose enough? 76
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 76
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 74
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 74
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 73
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 73
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 73
Can we really identify HIV-1 long-term nonprogressors? 72
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 70
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 69
Inflammatory pseudotumor of lymph nodes. 68
Oxaliplatin Based Chemotherapy and Concomitant Highly Active Antiretroviral Therapy in the Treatment of 24 Patients with Colorectal Cancer and HIV Infection 68
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 68
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 68
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 63
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 62
The major genetic determinants of HIV-1 control affect HLA Class I Peptide presentation 61
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 60
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 60
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 60
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 58
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 58
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose 57
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 56
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 56
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 56
The treatment of latent TB infection in HIV-positive people: the Verona experience 51
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 51
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 51
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 49
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 48
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 46
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 45
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 45
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital 39
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir dose. 37
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 10
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 5
Totale 3.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.709
article - articoli 11.709
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.418
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 4 15
2019/2020481 62 16 6 28 59 69 44 27 10 46 47 67
2020/2021454 54 62 21 53 65 47 11 32 21 19 46 23
2021/2022489 44 151 4 66 6 8 5 22 26 15 32 110
2022/20231.035 58 137 83 164 100 256 3 71 122 6 20 15
2023/2024375 26 45 52 39 63 84 6 26 6 28 0 0
Totale 3.693